ORD 55063/2024

—·EP3977921: ANALYTE SENSOR AND APPARATUS FOR INSERTION OF THE SENSOR

Case details: Status
—
Action
Procedural application
Category
Case Management Orders
Parties: Claimants
Abbott Diabetes Care Inc.
Reps: Wim Maas
Respondents
DexCom, Inc.
Dexcom International Limited
Reps: Tjibbe Douma
Division: Nordic-Baltic RD
Judges: Stefan Johansson · Presiding Judge
Kai Härmand · Judge-Rapporteur
Pierluigi Perrotti · Legally Qualified Judge
Technology: Biotechnology
Language: —
First decided: Oct 7, 2024

Decisions

2024-10-07
Generic Order
Nordic-Baltic Regional Division (judge-rapporteur Kai Härmand) preliminary/case management order in Abbott Diabetes Care Inc.'s infringement action against Dexcom Inc. and Dexcom International Limited concerning EP 3 977 921 (a continuous glucose monitoring patent). The order addresses multiple pending applications including Abbott's R. 190 application to communicate information (partially dismissed following Paris LD precedent), Abbott's R. 191 application (found admissible but not justified), Abbott's application to change the statement of claim, Dexcom's request for security for legal costs, and sets procedural deadlines and oral hearing preparation steps.
Legal issues:Application to communicate information (R. 191 RoP / Art. 67 UPCA) – admissible but not justifiedR. 190 RoP evidence orderAmendment of statement of claimSecurity for legal costsPending EPO opposition proceedingsProcedural deadlines and oral hearing preparation

Documents